Back to the articles list | Back to browse issues page

XML Print

Mitigation of Scale-Up Risks in Technology Transfer of Vaccines and other Bioproducts
Vahid Marandi *
Pasteur Institute of Iran
Abstract:   (171 Views)
This article explores the subject of mitigating the risks associated with technology transfer in the bioproduction sector such as vaccine industries, which is a challenging and multifaceted process. Based on an examination of case study data, industry reports, and insights gained from over 20 years of bioprocessing experience, it is evident that a comprehensive understanding of the variables involved and meticulous attention to detail are necessary for successful scale-up. Key technological factors include strict regulatory compliance, equipment compatibility, and optimization of process parameters. Organizations can minimize the risks associated with scaling up bioproduction processes and effectively manage the complexities of technology transfer by implementing data-driven strategies and advanced modeling tools.
Keywords: Commercialization, Design Engineering, Bioproduction, Planning, Quality
Full-Text [PDF 237 kb]   (90 Downloads)    
Type of Study: Short communication | Subject: Vaccine production and manufacturing
Received: 2024/06/30
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.